Skip to main content
Clinical Trials/CTRI/2012/08/002871
CTRI/2012/08/002871CompletedPhase 4

Gut microbiome: Role in pathogenesis of enthesitis-related arthritis (ERA) form of juvenile idiopathic arthritis

Department of Biotechnology DBT Government of India0 sites46 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
46

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Diagnosis of JIA-ERA as per ILAR criteria
  • 2.Active disease as defined by presence of active arthritis (swollen joints)/enthesitis with elevated erythrocyte sedimentation rate ( >30 mm in first hour).
  • 3.Consent to participate in the study

Exclusion Criteria

  • 1.Use of antibiotics in the previous 6 weeks
  • 2.History of diarrhea in the previous 6 weeks
  • 3.Use of drugs that alter gut motility in the previous 6 weeks
  • 4.Use of corticosteroids or disease-modifying anti-rheumatic drugs (DMARDs)

Investigators

Sponsor
Department of Biotechnology DBT Government of India

Similar Trials

Not yet recruiting
Not Applicable
The role of the gut microbiome in the pathogenesis of IgA nephropathyglomerulonephritis
NL-OMON49937Radboud Universitair Medisch Centrum150
Completed
Not Applicable
The influence of the intestinal microbiome on the development of postoperative complications after elective colon surgery - a prospective cohort studyK91.83T79.3Post-traumatic wound infection, not elsewhere classified
DRKS00014059niversitätsklinikum FreiburgInstitut für Umweltmedizin und KrankenhaushygieneUni-Zentrum Naturheilkunde127
Completed
Not Applicable
Study of the involvement of the gut microbiota in the pathophysiology and treatment effect of patients with unresectable hepatocellular carcinoma.Hepatocellular carcinoma
JPRN-UMIN000042709Kurume university60
Completed
Not Applicable
Clarification of gut microbiota in patients with esophageal cancer closely related to a life style.esophageal cancer
JPRN-UMIN000036882Kyushu University20
Recruiting
Not Applicable
A role of gut microbiota in the pathogenesis of gastrointestinal and liver diseases and the clinical applicatio1)Nonalcoholic steatohepatitis (NASH) 2)Alcoholic hepatitis (ASH) 3)Liver cirrhosis due to NASH, ASH, viral hepatitis, Autoimmune hepatitis , Primary biliary cirrhosis, and Primary sclerosing cholangitis 4)Hepatocellular carcinoma 5)Ulcerative colitis 6)Crohn&#39s diseases 7)Intestinal Behcet&#39s diseases 8)Chronic nonspecific multiple ulcers of the small intestine 9)Autoimmune pancreatitis 10)Eosinophilic esophagitis and gastritis 11)Functional dyspepsia 12)Irritable bowel diseases 13)Diabetes mellitus 14)Simple obesity
JPRN-UMIN000018068Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine260
Trial to study the gut microbiome in... | Clinical Trial